{
  "company": {
    "name": "Aulos Bioscience",
    "website": "https://aulosbio.com/",
    "record": "https://startuphistory.org/c/aulosbio.com"
  },
  "status": null,
  "history_since": "2021-01-08T16:43:32.000Z",
  "baseline": {
    "snapshot_id": "c03c72e41591afb28e9b0f9493b12e589482c3e2495ae98000fb9c259f91a0ab",
    "observed_at": "2021-01-08T16:43:32.000Z",
    "headline": "A new direction for IL‑2 in immuno‑oncology",
    "description": null,
    "evidence": "https://web.archive.org/web/20210108164332/https://www.aulosbio.com/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [],
          "funding": [
            "The founder of three biotech companies, Yanay has raised over $100 million from top venture capitalists and strategic investors."
          ]
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 2,
  "last_checked": "2026-11-06T14:26:48.532Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2021-09-22T09:15:21.000Z",
      "variants": [
        {
          "headline": "A new direction for IL‑2 in immuno‑oncology",
          "subhead": null,
          "observed_at": "2021-01-08T16:43:32.000Z",
          "evidence": "https://web.archive.org/web/20210108164332/https://www.aulosbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "A new direction for IL‑2 in immuno‑oncology",
          "subhead": "Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.",
          "observed_at": "2021-09-22T09:15:21.000Z",
          "evidence": "https://web.archive.org/web/20210922091521/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "A new direction for IL‑2 in immuno‑oncology",
      "subhead": "Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.",
      "from": "2021-01-08T16:43:32.000Z",
      "to": "2021-09-22T09:15:21.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20210922091521/https://aulosbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-01-08T16:43:32.000Z",
          "to": "2021-09-22T09:15:21.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2023-01-22T00:41:53.000Z",
      "variants": [
        {
          "headline": "Revolutionizing cancer care through IL2 therapeutics | Aulos Bioscience",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2022-01-16T21:14:04.000Z",
          "evidence": "https://web.archive.org/web/20220116211404/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Revolutionizing cancer care through IL2 therapeutics | Aulos Bioscience",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2023-01-22T00:41:53.000Z",
          "evidence": "https://web.archive.org/web/20230122004153/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Revolutionizing cancer care through IL2 therapeutics | Aulos Bioscience",
      "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
      "from": "2022-01-16T21:14:04.000Z",
      "to": "2023-01-22T00:41:53.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20230122004153/https://aulosbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2022-01-16T21:14:04.000Z",
          "to": "2023-01-22T00:41:53.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T14:26:48.532Z",
      "variants": [
        {
          "headline": "Boosting Immunity and Restoring Hope",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2023-07-10T01:37:56.000Z",
          "evidence": "https://web.archive.org/web/20230710013756/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Boosting Immunity and Restoring Hope",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2024-01-03T18:15:27.000Z",
          "evidence": "https://web.archive.org/web/20240103181527/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Boosting Immunity and Restoring Hope",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2024-07-16T22:17:24.000Z",
          "evidence": "https://web.archive.org/web/20240716221724/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Boosting Immunity and Restoring Hope",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2025-07-18T00:20:12.000Z",
          "evidence": "https://web.archive.org/web/20250718002012/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Boosting Immunity and Restoring Hope",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2026-01-12T16:22:41.000Z",
          "evidence": "https://web.archive.org/web/20260112162241/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Boosting Immunity and Restoring Hope",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2026-04-21T18:22:02.000Z",
          "evidence": "https://web.archive.org/web/20260421182202/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Boosting Immunity and Restoring Hope",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2026-10-02T14:27:12.000Z",
          "evidence": "https://web.archive.org/web/20261002142712/https://aulosbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Boosting Immunity and Restoring Hope",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2026-11-05T11:39:26.327Z",
          "evidence": "https://aulosbio.com/",
          "evidence_kind": "live_capture"
        },
        {
          "headline": "Boosting Immunity and Restoring Hope",
          "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
          "observed_at": "2026-11-06T14:26:48.532Z",
          "evidence": "https://aulosbio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Boosting Immunity and Restoring Hope",
      "subhead": "Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.",
      "from": "2023-07-10T01:37:56.000Z",
      "to": "2026-11-06T14:26:48.532Z",
      "captures": 9,
      "evidence": "https://aulosbio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2023-07-10T01:37:56.000Z",
          "to": "2026-11-06T14:26:48.532Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-c7d620e496107a46681485c7c8d2ecb1bc2f069cb6048aa083599cd27e734135:f510b6694f6664c647b4015ef87cbbfa90b76f58f071e80e780235224dcc6a8e:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20210922091521/https://aulosbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2021-09-22T09:15:21.000Z",
        "to": "2022-01-16T21:14:04.000Z"
      },
      "evidence": "https://web.archive.org/web/20220116211404/https://aulosbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Aulos Bioscience” company record, https://startuphistory.org/c/aulosbio.com"
}